CFLT vs REGN · rev $963.6M vs P/E 14, rev $14.34B
Confluent Inc (CFLT) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Confluent Inc (CFLT) is a software - infrastructure company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported CFLT revenue for 2024-12-31 was $963.6M. Net income was -$345.1M. Revenue was up 24.0% from 2023-12-31 to 2024-12-31. CFLT currently screens at market cap $11.13B.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
CFLT currently screens at market cap $11.13B. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the CFLT and REGN stock pages for the full models.
Not investment advice.